(Approval lapsed 14/01/2020) Rizatriptan 10mg Orodisperible Tablets (Actavis)
Section 19A approved medicine
(Approval lapsed 14/01/2020) Rizatriptan 10mg Orodisperible Tablets (Actavis)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Lapsed
Medicines in short supply/unavailable
MAXALT rizatriptan (as benzoate) 10mg wafer blister pack - ARTG 69076
Indication(s)
For the acute treatment of migraine attacks with or without aura